Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From May 29, 2023

Alkem Launches Biosimilar To Treat Head, Neck Cancer

Alkem launches biosimilar to treat head, neck cancer

Alkem Launches Biosimilar To Treat Head, Neck Cancer
Alkem Labs' R&D facility. (Photo: Company website)
STOCKS IN THIS STORY
Nifty MidSmall India Consumption
--

Alkem Laboratories on Monday said it has launched Cetuxa, the world's first biosimilar of Cetuximab, used for the treatment of head and neck cancer.

The introduction of the medication is in line with the company's endeavour to ensure affordability, accessibility and availability while saving the lives of critically ill cancer patients, the drug maker said in a statement.

Cetuxa is administered as an intravenous infusion and is available as 100 mg (2 mg/mL) in a single-dose vial.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

"In India, more than 76,000 patients are eligible for the use of cetuximab for the management of head and neck cancer. Currently, only around 1,611 patients are managed by this therapy...Its reach in India is limited partly due to its high cost. To address this issue, we have launched an affordable biosimilar, which is backed by indigenous research and production," Alkem Laboratories Managing Director Sandeep Singh said.

Head and neck cancer is one of the most prevalent cancers in India, which is primarily caused by the consumption of tobacco.

According to the Global Cancer Observatory estimates, there were 19.3 million incident cancer cases worldwide in 2020 and India ranked third after China and the U.S.

Overall, 57.5% of global head and neck cancer cases occur in Asia, and India accounts for 30% of these cases.

Annually, in India, the prevalence of head and neck cancer is around 5,00,000 cases with over 1,25,000 deaths.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Listen to the latest songs, only on JioSaavn.com